Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB26FY2R1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,124
Award facts
- Contract value 100% obligated
- $4,124.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL injections with a ceiling value of $4,124.22. This competitive, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of November 12, 2025, and is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to deliver a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through this prime IDC vehicle, which supports customers including the Defense Health Agency and the U.S. Coast Guard. The company's contract portfolio demonstrates extensive experience delivering diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies to federal healthcare systems. This specific delivery order for Ozempic, an injectable diabetes medication, reflects the company's ongoing role in supplying specialty pharmaceuticals to military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FY2R1?
SPE2DB26FY2R1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DB26FY2R1 worth?
The government has obligated $4,124 on SPE2DB26FY2R1.
Is contract SPE2DB26FY2R1 an order under another contract?
Yes. SPE2DB26FY2R1 is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB26FY2R1 competed?
The extent of competition for SPE2DB26FY2R1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award